A

Adaptimmune Therapeutics plc
D

ADAP

0.34760
USD
0.02
(4.60%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
92,131,933
أصول ذات صلة
L
LYFT
-0.070
(-0.49%)
14.295 USD
P
PTON
0.12000
(1.86%)
6.55500 USD
ROKU
ROKU
0.100
(0.11%)
90.140 USD
SNAP
SNAP
0.03500
(0.36%)
9.77500 USD
SPOT
SPOT
11.73
(1.72%)
692.70 USD
TTD
TTD
1.120
(1.32%)
86.150 USD
ZM
ZM
-0.820
(-1.08%)
74.830 USD
المزيد
الأخبار المقالات

العنوان: Adaptimmune Therapeutics plc

القطاع: Healthcare
الصناعة: Biotechnology
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.